Brazil
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
24.35%
|
Dec. 31, 2023 | USD 2.07 | -3.18% |
|
Brazil |
|
2 |
14.94%
|
Dec. 31, 2023 | USD 16.15 | -4.10% |
|
Brazil |
|
3 |
8.60%
|
Dec. 31, 2023 | USD 1.99 | 0.58% |
|
Brazil |
|
4 |
8.21%
|
Dec. 31, 2023 | USD 2.01 | 1.12% |
|
Brazil |
|
5 |
5.48%
|
Dec. 31, 2023 | USD 4.84 | -1.29% |
|
Brazil |
|
6 |
-6.99%
|
Dec. 31, 2023 | USD 0.31 | -3.93% |
|
Brazil |
|
7 |
-16.91%
|
Dec. 31, 2023 | USD 1.75 | -1.08% |
|
Brazil |
|
8 |
-68.36%
|
Dec. 31, 2023 | USD 1.67 | 1.07% |
|
Brazil |
The Biotechnology company in Brazil with the highest EBT Margin is Blau Farmacêutica S.A. (São Paulo Stock Exchange: BLAU3.SA) at 24.35%.
The Biotechnology company in Brazil with the lowest EBT Margin is Biomm S.A. (São Paulo Stock Exchange: BIOM3.SA) at -68.36%.
The top 10 Biotechnology companies in Brazil by EBT Margin are Blau Farmacêutica S.A., Afya Limited, Baumer S.A., Fleury S.A., Rede D'Or São Luiz S.A., Diagnósticos da América S.A., Centro de Imagem Diagnósticos S.A. and Biomm S.A..
The bottom 10 Biotechnology companies in Brazil by EBT Margin are Biomm S.A., Centro de Imagem Diagnósticos S.A., Diagnósticos da América S.A., Rede D'Or São Luiz S.A., Fleury S.A., Baumer S.A., Afya Limited and Blau Farmacêutica S.A..